A Randomized Clinical Trial of Cutaneous Xylocaine Spray to Reduce Intravenous Cannulation Pain in Adults.

Completed

• Conditions: Pijnstillend effect van cutaan aangebrachte xylocaine spray voor plaatsing van een infuus.; effective painkiller; Pain

• Registration Number: NL-OMON43666
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 17

Inclusion Criteria

Adults (aged 18 or older
Signing of the informed consent paper

Exclusion Criteria

Allergy for xylocaine
Pregnancy or breast-feeding
Peripheral neuropathy
Analgesics in the last 24 hours
Skin conditions (eczema, psoriasis, infection, or abrasions)
Difficulties in verbal communication
No intravenous access in both elbows possible (eg status after axillary dissection )

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome: The pain score of the tested subjects during intravenous<br /><br>cannulation</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary outcome(s):<br /><br>- Complications or adverse reactions of xylocaine spray<br /><br>- Influence of xylocaine spray in successfully placing an IV cannulation<br /><br>- The degree of difficulty in successfully placing an IV cannulation</p><br>